+499.5%
MRNA vs BP
+34.1%
+465.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | BP | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.5% | -2.8% | -2.1% |
| 7D | +5.5% | +3.9% | +1.5% | +6.3% |
| 30D | +158.7% | +7.6% | +151.1% | +163.7% |
| 3M | +182.1% | +0.7% | +181.4% | +187.7% |
| 6M | +151.8% | +15.5% | +136.3% | +156.4% |
| YTD | +393.6% | +30.8% | +362.7% | +404.0% |
| 1Y | +499.5% | +34.3% | +465.2% | +517.2% |
| All | +499.5% | +34.1% | +465.4% | +517.2% |
Cumulative growth
Daily Returns
Daily percentage return beside BP.
Daily Out/Under-Performance
Portfolio return minus BP return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded BP wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling